{"id":32851,"date":"2023-08-24T14:58:16","date_gmt":"2023-08-24T14:58:16","guid":{"rendered":"https:\/\/www.theisn.org\/?page_id=32851"},"modified":"2026-09-09T13:32:37","modified_gmt":"2026-09-09T13:32:37","slug":"trending-topics","status":"publish","type":"page","link":"https:\/\/www.theisn.org\/news\/trending-topics\/","title":{"rendered":"Trending Topics"},"content":{"rendered":"<p>[vc_row el_class=&#8221;trending&#8221;][vc_column][vc_single_image image=&#8221;54148&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221; css=&#8221;.vc_custom_1780299543613{margin-bottom: 0px !important;padding-bottom: 10px !important;}&#8221;][vc_column_text css=&#8221;.vc_custom_1788950982413{margin-bottom: 20px !important;border-top-width: 2px !important;padding-top: 25px !important;border-top-color: #00337c !important;border-top-style: solid !important;}&#8221;]Explore highly downloaded* research and real-world clinical insights from <a title=\"Original URL: https:\/\/theisn.us2.list-manage.com\/track\/click?u=30ed93011f8c63cbd569147d6&amp;id=a1be7a4bab&amp;e=091f3a715c Click to follow link.\" href=\"https:\/\/kidneyinternational-online.org\/\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"6acb7738-5bcb-4ee5-85a0-edf5b2c04a60\"><em>Kidney International<\/em><sup>\u00ae<\/sup><\/a>, <a title=\"Original URL: https:\/\/theisn.us2.list-manage.com\/track\/click?u=30ed93011f8c63cbd569147d6&amp;id=4b257d3768&amp;e=091f3a715c Click to follow link.\" href=\"https:\/\/www.kireports.org\/\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"f13befa1-22ed-4f0d-ab58-0616dc47da19\"><em>Kidney International Reports<\/em><sup>\u00ae<\/sup><\/a>, and <a title=\"Original URL: https:\/\/theisn.us2.list-manage.com\/track\/click?u=30ed93011f8c63cbd569147d6&amp;id=2e827f9a2b&amp;e=091f3a715c Click to follow link.\" href=\"https:\/\/www.kicasereports.org\/\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"ee84835c-213a-4fc9-beb0-639ff278245d\"><em>Kidney International Case Reports<\/em><sup>\u2122<\/sup><\/a>.<\/p>\n<p>Turn your clinical experience into global knowledge with <em>Kidney International Case Reports<\/em><sup>\u2122<\/sup>. <a title=\"Original URL: https:\/\/theisn.us2.list-manage.com\/track\/click?u=30ed93011f8c63cbd569147d6&amp;id=b5cb90618d&amp;e=091f3a715c Click to follow link.\" href=\"https:\/\/www.theisn.org\/blog\/2026\/02\/23\/sharing-bedside-lessons-writing-a-case-report-for-kidney-international-case-reports\/\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"2e99e0fc-3dc6-42c3-bb8c-8c1daa2caeab\">Find out how to submit your work<\/a> and fast-track your findings with rapid review.<\/p>\n<p style=\"text-align: right;float: right\"><span class=\"update-date\">LAST UPDATED: Sept 4, 2026<\/span><\/p>\n<h3>Trending this week<\/h3>\n<p>[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1788951132352{margin-bottom: 20px !important;}&#8221;]<\/p>\n<div style=\"height: 60px\">\n<div style=\"float: left\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-54149\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2026\/06\/logo-KI-300x110.png\" alt=\"\" width=\"150\" height=\"55\" \/><\/div>\n<div style=\"text-align: right;margin-top: 10px\"><a class=\"btn btn-default\" href=\"https:\/\/kidneyinternational-online.org\/article\/S0085-2538(26)00540-5\/fulltext\" target=\"_blank\" rel=\"noopener\">In this issue: Sept&#8217;26<\/a><\/div>\n<\/div>\n<p>[\/vc_column_text][vc_column_text el_class=&#8221;December&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00213-9\/fulltext\" target=\"_blank\" rel=\"noopener\">Complement inhibitors and B cell\u2013modifying agents for IgA nephropathy\u2014a Kidney Disease: Improving Global Outcomes (KDIGO) commentary<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/kidneyinternational-online.org\/article\/S0085-2538(26)00406-0\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"502dd728-aee4-47ed-a974-24b736e5f017\">Renal biopsy in patients with diabetes: still going strong after all these years<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/kidneyinternational-online.org\/article\/S0085-2538(26)00397-2\/fulltext\" target=\"_blank\" rel=\"noopener\">A post hoc analysis of BLISS-LN found Belimumab plus mycophenolate mofetil improves kidney outcomes versus placebo plus mycophenolate mofetil in active lupus nephritis<\/a><\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1788951170934{margin-bottom: 20px !important;}&#8221;]<\/p>\n<div style=\"height: 60px\">\n<div style=\"float: left\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-54149\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2026\/06\/logo-KIR-300x73.png\" alt=\"\" width=\"160\" height=\"39\" \/><\/div>\n<div style=\"text-align: right;margin-top: 10px\"><a class=\"btn btn-default\" href=\"https:\/\/www.kireports.org\/current\" target=\"_blank\" rel=\"noopener\">Current issue: Sept&#8217;26<\/a><\/div>\n<\/div>\n<p>[\/vc_column_text][vc_column_text el_class=&#8221;November&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<p class=\"post-item-title\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)03221-3\/fulltext\" target=\"_blank\" rel=\"noopener\">Nephrologist workforce capacity and kidney disease burden in Mexico<\/a><\/p>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)03222-5\/fulltext?\" target=\"_blank\" rel=\"noopener\">An international expert consensus statement and guidance document on implementation of nutritional supplementation in patients on dialysis<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)03241-9\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"4e74f27b-14f7-4761-b85b-cd2714ed0846\">Rituximab with or without avacopan in ANCA-associated vasculitis with severe renal involvement<\/a><\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text css=&#8221;.vc_custom_1785230232946{margin-bottom: 20px !important;}&#8221;]<\/p>\n<div style=\"height: 60px\">\n<div style=\"float: left\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-54157\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2026\/06\/logo-KICR-300x46.png\" alt=\"\" width=\"260\" height=\"40\" \/><\/div>\n<div style=\"text-align: right;margin-top: 10px\"><a class=\"btn btn-default\" href=\"https:\/\/www.kicasereports.org\/current\" target=\"_blank\" rel=\"noopener\">Current issue: June&#8217;26<\/a><\/div>\n<\/div>\n<p>[\/vc_column_text][vc_column_text el_class=&#8221;November&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKICR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00059-2\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"464673dc-eb64-4bab-a147-6e61cdaa12af\">Stress-related nonosmotic antidiuretic hormone release causing acute hyponatremia with abrupt resolution following sedation<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\"><a class=\"articleKICR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00047-6\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"d1a4bb77-4f01-431b-bb92-0863df128607\">Phospholipase A2 receptor-associated membranous nephropathy with 4 separate malignancy episodes: a case report<\/a><\/li>\n<li class=\"porto-info-list-item\"><a class=\"articleKICR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00053-1\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"7dd55d4a-1fbd-4a7f-b1e4-c023b91eb047\">Minor mycosis with major interaction: tacrolimus intoxication after tinea pedis treatment in a kidney transplant recipient<\/a><\/li>\n<\/ul>\n<p>[\/vc_column_text][vc_column_text]<\/p>\n<h3>Previously trending<\/h3>\n<p>[\/vc_column_text][vc_tta_accordion c_position=&#8221;right&#8221; active_section=&#8221;&#8221; collapsible_all=&#8221;true&#8221; el_class=&#8221;accordion-isn&#8221;][vc_tta_section title=&#8221;2026&#8243; tab_id=&#8221;2026&#8243; el_class=&#8221;ul-text&#8221;][vc_column_text css=&#8221;.vc_custom_1785229801020{margin-bottom: 20px !important;}&#8221;]<img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-54149\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2026\/06\/logo-KI-300x110.png\" alt=\"\" width=\"150\" height=\"55\" \/>[\/vc_column_text][vc_toggle title=&#8221;January&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00861-0\/fulltext\" target=\"_blank\" rel=\"noopener\">REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00879-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Severe hypertension with thrombotic microangiopathy: The need for pathogenically targeted treatments<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00748-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Mineralocorticoid receptor inhibition in parietal epithelial cells prevents focal segmental glomerulosclerosis and crescentic glomerulonephritis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00495-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00762-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Critical role of transcription factor SOX4 in tubular epithelial cell dedifferentiation and fibroblast activation during kidney fibrosis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00772-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Hierarchical clustering uncovered disease patterns and further untangled complexities in immune complex-mediated idiopathic MPGN and C3 glomerulopathy<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;February&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00847-6\/fulltext\" target=\"_blank\" rel=\"noopener\">From progression to remission: a new paradigm for success in chronic kidney disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00774-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00861-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00479-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00845-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">SGLT-2 inhibition in pediatric CKD: Advances, challenges, and opportunities<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538%2825%2900855-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Preclinical evaluation of antigen-specific B-cell depletion for phospholipase A2 receptor membranous nephropathy with chimeric autoantibody receptor T cells<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;March&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00494-6\/fulltext\" target=\"_blank\" rel=\"noopener\">Executive summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00989-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Population-based estimated glomerular filtration rate distributions and associated health outcomes provide opportunities for early identification of and primary prevention of chronic kidney disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)01020-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Sodium-glucose co-transporter 2 inhibition improves age-dependent kidney microvascular rarefaction<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00884-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Kidney disease and heart failure: Recent advances and current challenges: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)01030-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Kidney health for all: Caring for people, protecting the planet<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)01007-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A single-arm phase 2 trial of an investigational RNA therapeutic to complement factor B sefaxersen for treatment of IgA nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;April&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)01025-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The expanding role of complement inhibitors in the treatment of IgA nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00079-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Green dialysis: Environmentally sustainable care, growth, and innovation: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00005-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00005-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Complement inhibitors and B cell\u2013modifying agents for IgA nephropathy\u2014a Kidney Disease: Improving Global Outcomes (KDIGO) commentary<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00005-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Finding the etiology of membranoproliferative glomerulonephritis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00005-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Nobel prize\u2013winning Treg cells in autoimmune kidney diseases and transplantation<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;May&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" title=\"Original URL: https:\/\/theisn.us2.list-manage.com\/track\/click?u=30ed93011f8c63cbd569147d6&amp;id=f6c3726a04&amp;e=091f3a715c Click to follow link.\" href=\"https:\/\/eur05.safelinks.protection.outlook.com\/?url=https%3A%2F%2Ftheisn.us2.list-manage.com%2Ftrack%2Fclick%3Fu%3D30ed93011f8c63cbd569147d6%26id%3Df6c3726a04%26e%3D091f3a715c&amp;data=05%7C02%7Crparmar%40theisn.org%7Cef96b108f4044dde627408debd58cf08%7C9353336200694ec4b905d4dcc7a8a0ef%7C0%7C0%7C639156386289538950%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=BCPjbO8psDdj%2BDgNo%2FEeJlxvTpVaY2twBZtfh1lwB%2B4%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"df38abc7-a90e-4c29-bc00-2fc1c8001f44\">Association between the gut microbiota and estimated glomerular filtration rate in two Swedish population-based cohorts<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" title=\"Original URL: https:\/\/theisn.us2.list-manage.com\/track\/click?u=30ed93011f8c63cbd569147d6&amp;id=c73049927e&amp;e=091f3a715c Click to follow link.\" href=\"https:\/\/eur05.safelinks.protection.outlook.com\/?url=https%3A%2F%2Ftheisn.us2.list-manage.com%2Ftrack%2Fclick%3Fu%3D30ed93011f8c63cbd569147d6%26id%3Dc73049927e%26e%3D091f3a715c&amp;data=05%7C02%7Crparmar%40theisn.org%7Cef96b108f4044dde627408debd58cf08%7C9353336200694ec4b905d4dcc7a8a0ef%7C0%7C0%7C639156386289560890%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=Cd4pupFHEwxJ93OJ%2Bx2Bfwl30vApfR%2F8b8ME8RaerLs%3D&amp;reserved=0\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"502dd728-aee4-47ed-a974-24b736e5f017\">A randomized controlled non-inferiority trial examined lower dose prednisolone and activated vitamin D in adult minimal change podocytopathy<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00091-8\/fulltext\" target=\"_blank\" rel=\"noopener\">A population-based, regression discontinuity analysis examined the effects of nationwide alerting for acute kidney injury on health care and patient outcomes<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00226-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Primary hyperoxaluria(s): From trials to real-life data and pipeline therapies<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00010-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Multi-omics analyses reveal the pathogenic role of terminal ileum-derived IgA+\u03b27+ cells in IgA nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00011-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Taking the \u201cunknown\u201d out of CKDu\u2014optimizing approaches to uncover the cause(s) of epidemic-level kidney disease in low- and middle-income settings: a report from the ISN\u2019s International Consortium of CKDu Collaborators (ISN i3C)<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00226-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Targeting B cells in immune-mediated kidney diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00009-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Sodium glucose transporter 2 inhibition maintains kidney antibacterial response by decreasing complement C1q<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00145-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Tiny warriors, big impact: Targeted immunotherapy in kidney diseases<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;June&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00223-1\/abstract\" target=\"_blank\" rel=\"noopener\">Conventional cytotoxic chemotherapy\u2013associated nephrotoxicity: consensus report of the 34th Acute Disease Quality Initiative (ADQI) Workgroup<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00164-X\/fulltext\" target=\"_blank\" rel=\"noopener\">Anti-PLA2R1 IgG-mediated podocyte PLA2R1 cleavage drives glomerular subepithelial immune complex deposition in membranous nephropathy<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/kidneyinternational-online.org\/article\/S0085-2538(26)00217-6\/fulltext\" target=\"_blank\" rel=\"noopener\">A double-blind, randomized, placebo-controlled, phase 2 trial examined the efficacy and safety of monlunabant in adults with diabetic kidney disease<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/kidneyinternational-online.org\/article\/S0085-2538(26)00244-9\/abstract\" target=\"_blank\" rel=\"noopener\">T-cell engagers mediate deep cell depletion beyond autoimmunity<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/kidneyinternational-online.org\/article\/S0085-2538(26)00092-X\/fulltext\" target=\"_blank\" rel=\"noopener\">B-cell maturation antigen-targeted T-cell engager therapy combined with B-cell depletion for treatment of refractory HLA sensitization<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00012-8\/fulltext\" target=\"_blank\" rel=\"noopener\">Kidney Disease: Improving Global Outcomes (KDIGO): navigating a rapidly changing landscape<\/a><\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;July&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" title=\"Original URL: https:\/\/theisn.us2.list-manage.com\/track\/click?u=30ed93011f8c63cbd569147d6&amp;id=f6c3726a04&amp;e=091f3a715c Click to follow link.\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00407-2\/fulltext\">The kidney in the middle: Kidney Disease: Improving Global Outcomes (KDIGO) guidelines address multiple key components of cardiovascular-kidney-metabolic syndrome<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00306-6\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"502dd728-aee4-47ed-a974-24b736e5f017\">Reversal of advanced diabetic kidney disease in mice treated with a monoclonal anti-VEGFR1 antibody<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00238-3\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"588a8fa3-39eb-4513-ab49-9ea0a2ec71c5\">A prospective multicenter randomized controlled trial pre-emptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00884-1\/fulltext\" target=\"_blank\" rel=\"noopener\">Kidney disease and heart failure: Recent advances and current challenges: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/kidneyinternational-online.org\/article\/S0085-2538(26)00161-4\/abstract\" target=\"_blank\" rel=\"noopener\"><br \/>\nEvidence from multicenter clinical studies and humanized mouse models indicates that glomerular mesangial IgA2 deposition contributes to the pathogenesis of IgA nephropathy<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00211-5\/abstract\" target=\"_blank\" rel=\"noopener\"><br \/>\nKidney health without borders: a multilingual kidney education platform<\/a><\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;August&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00326-1\/fulltext\" target=\"_blank\" rel=\"noopener\">Tubulointerstitial diseases: an updated framework for diverse and emerging entities<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/kidneyinternational-online.org\/article\/S0085-2538(26)00405-9\/fulltext\" target=\"_blank\" rel=\"noopener\">Neonatal acute kidney injury: diagnosis, recognition, and prevention<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/kidneyinternational-online.org\/article\/S0085-2538(26)00401-1\/fulltext\" target=\"_blank\" rel=\"noopener\">Therapeutic efficacy and antigenicity of a novel PEGylated IgA protease in preclinical models of IgA nephropathy<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00233-4\/fulltext\" target=\"_blank\" rel=\"noopener\">Individual participant-level analysis of four randomized clinical trials examined therapeutic effects of blood pressure lowering on hierarchical kidney outcome using win statistics<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(26)00234-6\/fulltext\" target=\"_blank\" rel=\"noopener\">Genetic testing in kidney transplantation and living kidney donor risk assessment<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKI\" href=\"https:\/\/kidneyinternational-online.org\/article\/S0085-2538(26)00305-4\/fulltext\" target=\"_blank\" rel=\"noopener\">Clinical and histologic predictors of non-diabetic kidney disease in patients with diabetes mellitus<\/a><\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_column_text css=&#8221;.vc_custom_1788953422463{margin-bottom: 20px !important;}&#8221;]<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-54149\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2026\/06\/logo-KIR-300x73.png\" alt=\"\" width=\"160\" height=\"39\" \/>[\/vc_column_text][vc_toggle title=&#8221;January&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00599-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Defining disease modification in IgA nephropathy: Toward a paradigm shift in management<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00623-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Randomized trial of twice-weekly versus thrice-weekly hemodiafiltration for initiation of renal replacement therapy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00618-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Mass spectrometry of minimal change disease and focal segmental glomerulosclerosis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00662-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Infliximab for grade III or IV immune checkpoint inhibitor nephritis clinical and translational evidence<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00559-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Effect of baseline dialysis and plasma exchange on renal prognosis in patients with antineutrophil cytoplasmic autoantibody\u2013associated vasculitis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00609-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">From dialysis to destinations: Safe travel strategies for patients with CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;February&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00673-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Povetacicept for IgA nephropathy and primary membranous nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00625-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">CKDs at the crossroads: From failures to future therapies<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00716-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Complement-mediated kidney diseases: Role of alternative pathway in glomerular inflammation<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)00007-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Kidney outcomes in ANCA-glomerulonephritis according to induction immunosuppression and histopathology<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00684-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Recurrence of C3 glomerulopathy and immune complex\u2013mediated membranoproliferative glomerulonephritis after kidney transplantation: Challenges and opportunities<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00771-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Systematic review of efficacy and safety of avacopan in real-world clinical practice<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;March&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00664-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Current and emerging therapies for C3 glomerulopathy and primary (idiopathic) immune complex membranoproliferative glomerulonephritis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00601-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">From evidence to action: Advancing timely implementation of triple therapy in type 2 diabetes mellitus and CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00716-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Complement-mediated kidney diseases: Role of alternative pathway in glomerular inflammation<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00715-6\/fulltext?\" target=\"_blank\" rel=\"noopener noreferrer\">A FIDELITY analysis on finerenone with SGLT-2i and GLP-1RA in CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)00024-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Pathophysiological mechanism of Beni-koji Choleste-Help or puberulic acid\u2013induced kidney injury<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)00025-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Effect of steroids on anti-nephrin autoantibodies and B cells in minimal change disease<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;April&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249%2826%2902594-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Managing blood pressure in dialysis patients: A summary of UK clinical practice guideline<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249%2825%2900746-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Prospective cohort study of obinutuzumab in rituximab-resistant primary membranous nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249%2826%2902577-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Prevention of recurrent kidney stones: A CARI guidelines summary<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;May&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<p class=\"post-item-title\"><a class=\"articleKIR\" title=\"Original URL: https:\/\/theisn.us2.list-manage.com\/track\/click?u=30ed93011f8c63cbd569147d6&amp;id=a923e31451&amp;e=091f3a715c Click to follow link.\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02711-7\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Systematic review of trial design and end points in lupus nephritis<\/a><\/p>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" title=\"Original URL: https:\/\/theisn.us2.list-manage.com\/track\/click?u=30ed93011f8c63cbd569147d6&amp;id=cf1380c8a8&amp;e=091f3a715c Click to follow link.\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02715-4\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"2f4430f3-69a9-4f9a-85d5-8b08f7286e87\">The associations between dialysis treatment time, mortality, and hospitalizations in a large hemodialysis cohort<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" title=\"Original URL: https:\/\/theisn.us2.list-manage.com\/track\/click?u=30ed93011f8c63cbd569147d6&amp;id=48f6e74eb9&amp;e=091f3a715c Click to follow link.\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02593-3\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"4e74f27b-14f7-4761-b85b-cd2714ed0846\">Osteoporosis and CKD-metabolic bone disease under the same umbrella: Insights from a joint scientific symposium<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02643-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Enteric Budesonide treatment in IgA nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02586-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A multicenter randomized clinical trial of dapagliflozin in patients receiving chronic dialysis (The DARE-ESKD-2 Trial)<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02647-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Is obinutuzumab the answer to primary membranous nephropathy resistant to rituximab?<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02614-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Mortality and practice patterns in the MEXHEMO hemodialysis cohort<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02716-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Hidden in the Kidney: Renal-limited thrombotic microangiopathy without hemolysis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02762-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Enteric and controlled-release budesonide in IgA nephropathy: Expanding access while refining evidence<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;June&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02770-1\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Potential benefit of sodium-glucose cotransporter 2-inhibitors in cisplatin-associated nephrotoxicity among patients with cancer having diabetes mellitus<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02746-4\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Development and validation of a cystatin C-based staging of AKI in critically ill patients<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02773-7\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Missing opportunity for nephroprotective therapy in patients with non-dialysis CKD under stable nephrology care<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02764-6\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">The role of finerenone in cardiorenal protection and urine albumin-to-creatinine ratio modulation<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02726-9\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Dapagliflozin: A Role for heart failure treatment in dialysis?<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02798-1\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Sparsentan versus irbesartan in pediatric patients with FSGS<\/a><\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;July&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<p class=\"post-item-title\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02779-8\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Novel therapeutic strategies for patients with CKD and diabetes mellitus<\/a><\/p>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02725-7\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"2f4430f3-69a9-4f9a-85d5-8b08f7286e87\">Executive summary of evidence-based guidelines for the diagnosis and treatment of pediatric CKD-mineral and bone disorder (Version 2024)<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00549-2\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"4e74f27b-14f7-4761-b85b-cd2714ed0846\">CKD prevalence and associated factors in Jamaica<\/a><\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;August&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02862-7\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">IgG4-related kidney disease and IgG4-related retroperitoneal fibrosis: an update on diagnosis and treatment<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02941-4\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Causal effects of early discontinuation of proton pump inhibitors on kidney failure<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02791-9\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Randomized controlled trial of dapagliflozin for post-transplant diabetes mellitus in renal transplant recipients<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02895-0\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Real-time, multidisciplinary approach of women with pregnancy-associated thrombotic microangiopathy<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02777-4\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Post-hoc analysis on the effects of vicadrostat\/empagliflozin by CKD severity\/hypertension status<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kireports.org\/article\/S2468-0249(26)02790-7\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">ABO blood types and mortality in patients undergoing hemodialysis<\/a><\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_column_text css=&#8221;.vc_custom_1788953428403{margin-bottom: 20px !important;}&#8221;]<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-54157\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2026\/06\/logo-KICR-300x46.png\" alt=\"\" width=\"260\" height=\"40\" \/>[\/vc_column_text][vc_toggle title=&#8221;May&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00012-9\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Infliximab for drug-induced acute interstitial nephritis<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00016-6\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"2f4430f3-69a9-4f9a-85d5-8b08f7286e87\">Tizanidine withdrawal presenting as hypertensive emergency with recurrent AKI<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00020-8\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"2f4430f3-69a9-4f9a-85d5-8b08f7286e87\">Dueling fibrils. Concurrent ALECT2 amyloidosis and DNAJB9-positive fibrillary glomerulonephritis: A case report<\/a><\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;June&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00029-4\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Pegcetacoplan for refractory digital ischemia in C3 glomerulopathy with monoclonal gammopathy: A case report<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00027-0\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"2f4430f3-69a9-4f9a-85d5-8b08f7286e87\">Pleural and pericardial effusion in severe superior vena cava obstruction: A case report<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00038-5\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"2f4430f3-69a9-4f9a-85d5-8b08f7286e87\">Precision in diagnosis &#8211; KM55 (galactose deficient IgA1) staining in clinically diagnosed cases of systemic lupus erythematosus with IgA nephropathy<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00032-4\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Rescue of renal function after novel RNA interference therapy (Lumasiran) for catastrophic post\u2013kidney transplant recurrent oxalate nephropathy in primary hyperoxaluria type 1<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00019-1\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"2f4430f3-69a9-4f9a-85d5-8b08f7286e87\">Antiglomerular basement membrane antibody-associated rapidly progressive glomerulonephritis in a Patient with chromosome 10p deletion<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00026-9\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"2f4430f3-69a9-4f9a-85d5-8b08f7286e87\">Hypercalcemia unmasking several underlying disorders after vitamin D supplementation: A case report<\/a><\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;July&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKICR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00008-7\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"464673dc-eb64-4bab-a147-6e61cdaa12af\">A case of refractory IgA vasculitis nephropathy with nephrotic syndrome treated with daratumumab<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\"><a class=\"articleKICR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00023-3\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"d1a4bb77-4f01-431b-bb92-0863df128607\">Hemolysis in hindsight: Diagnostic challenges in delayed hemolytic transfusion reaction with AKI: A case report<\/a><\/li>\n<li class=\"porto-info-list-item\"><a class=\"articleKICR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00075-0\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"7dd55d4a-1fbd-4a7f-b1e4-c023b91eb047\">A fatal case of vanishing bile duct syndrome progressing to acute liver failure during avacopan therapy for microscopic polyangiitis<\/a><\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00035-X\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"e2ffb564-7a0f-4e71-913a-2935703e9edc\">Autosomal dominant tubulointerstitial kidney disease-UMOD presenting with advanced renal dysfunction in a 20-year-old woman: A case report<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00040-3\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"2f4430f3-69a9-4f9a-85d5-8b08f7286e87\">Nephrotic syndrome secondary to mantle cell lymphoma: A case report<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKIR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00034-8\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"2f4430f3-69a9-4f9a-85d5-8b08f7286e87\">Parvovirus B19\u2013associated cryoglobulinemic membranoproliferative glomerulonephritis in a kidney allograft: Balancing viral persistence and immunosuppression<\/a><\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;August&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKICR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00036-1\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"464673dc-eb64-4bab-a147-6e61cdaa12af\">Epstein-Barr virus-associated smooth muscle tumor in kidney transplant recipients: two cases and a literature review<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKICR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00006-3\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"464673dc-eb64-4bab-a147-6e61cdaa12af\">Sodium zirconium cyclosilicate: unexpected finding in management of hyperkalemia<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKICR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00096-8\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"464673dc-eb64-4bab-a147-6e61cdaa12af\">Oxalate nephropathy complicated by nephrotic syndrome and COVID-19 leading to end-stage kidney disease: a case report<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKICR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00050-6\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"464673dc-eb64-4bab-a147-6e61cdaa12af\">Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes diagnosed by genetic testing at a freestanding dialysis center: 2 dialysis cases highlighting the diagnostic role of nephrologists<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKICR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00025-7\/fulltext\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"464673dc-eb64-4bab-a147-6e61cdaa12af\">Immunosuppression in a patient with ANCA-associated vasculitis. How much is enough?<\/a><\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\"><a class=\"articleKICR\" href=\"https:\/\/www.kicasereports.org\/article\/S3117-471X(26)00078-6\/fulltext?\" target=\"_blank\" rel=\"noopener\" data-outlook-id=\"464673dc-eb64-4bab-a147-6e61cdaa12af\">Presumed shoshin beriberi presenting during the perioperative kidney transplant period: A case report<\/a><\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][\/vc_tta_section][vc_tta_section title=&#8221;2025&#8243; tab_id=&#8221;2025&#8243; el_class=&#8221;ul-text&#8221;][vc_column_text css=&#8221;.vc_custom_1692881874372{margin-bottom: 20px !important;}&#8221;]<img decoding=\"async\" class=\"alignnone wp-image-32927 size-full\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-46.png\" alt=\"\" width=\"500px\" \/>[\/vc_column_text][vc_toggle title=&#8221;January&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00479-4\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=3384b7fa91-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-3384b7fa91-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00777-4\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=3384b7fa91-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-3384b7fa91-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Evaluating the Risk of Cardiovascular Events Associated With Different Immunosuppression Treatments for Glomerular Diseases<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00909-8\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=3384b7fa91-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-3384b7fa91-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">A Nationwide Questionnaire Study Evaluated Kidney Injury Associated With Beni-koji Tablets in Japan<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00911-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Effects of Plasma Exchange and Glucocorticoids on Early Kidney Function Among Patients With ANCA-associated Vasculitis in the PEXIVAS Trial<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00697-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\"> New Insights Into Mechanisms Underlying Cognitive Impairment in Chronic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00564-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Differing Sensitivities to Angiotensin Converting Enzyme Inhibition of Kidney Disease Mediated by APOL1 High-risk Variants G1 and G2<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00407-1\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=502c64666e-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-502c64666e-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">A Genetically Inducible Endothelial Niche Enables Vascularization of Human Kidney Organoids With Multilineage Maturation and Emergence of Renin Expressing Cells<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00631-8\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=502c64666e-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-502c64666e-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Targeted Gene Therapy for Rare Genetic Kidney Diseases<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00619-7\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=502c64666e-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-502c64666e-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Hair-straightening Cosmetics Containing Glyoxylic Acid Induce Crystalline Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;February&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00076-6\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=c2252b1993-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-c2252b1993-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Treatment of Patients with IgA Nephropathy: A Call for a New Paradigm<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00810-X\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=c2252b1993-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-c2252b1993-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Chronic Kidney Disease\u2013Mineral and Bone Disorder: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00712-9\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=c2252b1993-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-c2252b1993-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Female Sex Hormones Inversely Regulate Acute Kidney Disease Susceptibility Throughout Life<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00792-0\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=5af72f2d40-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-5af72f2d40-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">A randomized controlled trial evaluated the efficacy and safety of apixaban for prevention of recurrent thrombosis after thrombectomy of hemodialysis vascular access<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00730-0\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=5af72f2d40-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-5af72f2d40-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Insights from the BKEVER trial comparing everolimus versus mycophenolate mofetil for BK polyomavirus infection in kidney transplant recipients<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00788-9\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=5af72f2d40-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-5af72f2d40-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">The critical role of endoplasmic reticulum stress and the stimulator of interferon genes (STING) pathway in kidney fibrosis<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;March&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00789-0\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=b91e9b13cd-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-b91e9b13cd-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Post-hoc analysis of the CARES trial suggests delayed progression of chronic kidney disease in patients with gout during urate-lowering therapy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00141-3\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=b91e9b13cd-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-b91e9b13cd-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">The prevention and management of chronic kidney disease among patients with metabolic syndrome<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00799-3\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=b91e9b13cd-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-b91e9b13cd-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Activating soluble guanylyl cyclase attenuates ischemic kidney damage<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00800-7\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=07774a6e6a-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-07774a6e6a-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">TRAIL induces podocyte PANoptosis via death receptor 5 in diabetic kidney disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00722-1\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=07774a6e6a-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-07774a6e6a-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Effects of dialysate potassium concentration of 3.0 mmol\/l with sodium zirconium cyclosilicate on dialysis-free days versus dialysate potassium concentration of 2.0 mmol\/l alone on rates of cardiac arrhythmias in hemodialysis patients with hyperkalemia<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00804-4\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=07774a6e6a-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-07774a6e6a-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">The autoimmune architecture of childhood idiopathic nephrotic syndrome<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;April&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00781-6\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=877ec880ff-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-877ec880ff-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Lupus nephritis: Redefining the treatment goals<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00910-4\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=877ec880ff-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-877ec880ff-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">International prevalence patterns of low eGFR in adults aged 18-60 without traditional risk factors from a population-based cross-sectional disadvantaged populations eGFR epidemiology (DEGREE) study<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00918-9\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=877ec880ff-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-877ec880ff-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Epigenetic alterations and memory: Key players in the development\/progression of chronic kidney disease promoted by acute kidney injury and diabetes<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;May&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00076-6\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=a8f813280d-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-a8f813280d-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Treatment of patients with IgA nephropathy: A call for a new paradigm<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00081-X\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=a8f813280d-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-a8f813280d-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">A kidney organoid-based readout to assess disease activity in primary and recurrent focal segmental glomerulosclerosis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00087-0\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=a8f813280d-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-a8f813280d-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Fibroblast growth factor 23 and fibroblast growth factor receptor 4 promote cardiac metabolic remodeling in chronic kidney disease<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00923-2\/abstract?utm_term=0_-dfd1b4090a-1431833767&amp;utm_campaign=dfd1b4090a-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_source=ISN+Mailing+list\" target=\"_blank\" rel=\"noopener noreferrer\">Multi-stain deep learning prediction model of treatment response in lupus nephritis based on renal histopathology<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00060-2\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=dfd1b4090a-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-dfd1b4090a-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">The membrane attack complex drives thrombotic microangiopathy in complement mediated atypical hemolytic uremic syndrome<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00065-1\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=dfd1b4090a-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-dfd1b4090a-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">The role of sex and gender in acute kidney injury\u2014consensus statements from the 33rd Acute Disease Quality Initiative<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;June&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00252-2\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=ad60fbadb5-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-ad60fbadb5-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Age- and sex-specific reference values of estimated glomerular filtration rate for European adults<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00067-5\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=ad60fbadb5-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-ad60fbadb5-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Melanocortin 5 receptor signaling protects against podocyte injury in proteinuric glomerulopathies<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00776-2\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=ad60fbadb5-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-ad60fbadb5-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: Results of a Nephcure membranous nephropathy workshop<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00082-1\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=474b66736c-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-474b66736c-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Anti-nephrin autoantibodies in steroid-resistant nephrotic syndrome may inform treatment strategy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00141-3\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=474b66736c-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-474b66736c-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">The prevention and management of chronic kidney disease among patients with metabolic syndrome<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00246-7\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=474b66736c-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-474b66736c-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Women and kidney health: Conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;July&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00334-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Preventing chronic kidney disease and maintaining kidney health: Conclusions from a \u201cKidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference\u201d<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00414-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Zigakibart demonstrates clinical safety and efficacy in a Phase 1\/2 trial of healthy volunteers and patients with IgA nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00085-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Mitochondrial dysfunction and mitophagy blockade contribute to renal osteodystrophy in chronic kidney disease-mineral bone disorder<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00326-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Gene signature-guided drug screening identified narciclasine as a potential therapeutic for interstitial fibrosis of the kidney<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00332-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Single-cell analysis of proximal tubular cells with different DNA content reveals functional heterogeneity in the acute kidney injury to chronic kidney disease transition<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00408-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Restoration of branched chain amino acid catabolism improves kidney function in preclinical cardiovascular-kidney-metabolic syndrome models<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;August&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00336-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Renal Pathology Society\/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy\u2013associated kidney lesions<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00491-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis using the United Kingdom RaDaR Registry<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00396-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00323-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rate in the prespecified FIDELITY pool analysis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00488-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00253-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Insights from ADPedKD, ERKReg and RaDaR registries provide a multi-national perspective on the presentation of childhood autosomal dominant polycystic kidney disease in high- and middle-income countries<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/kidneyinternational-online.org\/article\/S0085-2538(25)00395-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A nationwide register-based cohort study examined the association between preeclampsia in mothers and the risk of kidney disease in their offspring<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00409-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Clinical relevance of computationally derived tubular features and their spatial relationships with the interstitial microenvironment in minimal change disease\/focal segmental glomerulosclerosis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00509-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;September&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00406-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00490-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Kidney hepcidin protects the collecting duct against ferroptosis in ischemia\/reperfusion-induced acute kidney injury<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00419-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The podocyte gets a pedicure: Tiny nail clippers for podocyte foot processes<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00279-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">KDIGO 2025 clinical practice guideline for the management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;October&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00334-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Preventing chronic kidney disease and maintaining kidney health: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00488-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00567-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Patient preferences for kidney failure treatments<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00257-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Anti-nephrin antibodies in adult chinese patients with minimal change disease and primary focal segmental glomerulosclerosis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00485-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Artificial intelligence and perspective for rare genetic kidney diseases<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00489-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Urinary C-X-C-motif ligand 9 (CXCL9) in immune checkpoint inhibitor\u2013associated acute interstitial nephritis<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;November&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00509-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00506-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A systematic literature review and meta-analysis evaluated modifiable risk factors for the development of BK polyoma virus\u2013associated complications<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00585-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Where next for potassium binders in hemodialysis?<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00429-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">APOL1 kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;December&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00847-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">From progression to remission: A new paradigm for success in chronic kidney disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00479-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00861-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">REMODELing mechanistic trials for kidney disease: A multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00278-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">KDIGO 2025 clinical practice guideline for the management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00749-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Kidney injury and colocalization of complement C3, IgA, and IgG in glomerular immune-complex deposits of patients with IgA nephropathy or IgA vasculitis with nephritis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(25)00759-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The kidney slit diaphragm resembles a fishnet<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_column_text css=&#8221;.vc_custom_1692881881245{margin-bottom: 20px !important;}&#8221;]<img decoding=\"async\" class=\"alignnone wp-image-32927 size-full\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45.png\" alt=\"\" width=\"500px\" srcset=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45.png 1202w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-1024x72.png 1024w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-768x54.png 768w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-640x45.png 640w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-400x28.png 400w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-367x26.png 367w\" sizes=\"(max-width: 1202px) 100vw, 1202px\" \/>[\/vc_column_text][vc_toggle title=&#8221;January&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01962-4\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=3384b7fa91-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-3384b7fa91-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01946-6\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=3384b7fa91-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-3384b7fa91-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">In Defense of Age-based Estimated GFR Thresholds to Define CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)02040-0\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=3384b7fa91-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-3384b7fa91-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Anticomplement Therapies for C3 Glomerulopathy and Immune-Complex Membranoproliferative Glomerulonephritis Recurrence &#8211; A Dawn of New Hope<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01850-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">N-acetylcysteine in Kidney Disease: Molecular Mechanisms, Pharmacokinetics, and Clinical Effectiveness<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01961-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Efficacy and Safety of Pegcetacoplan in Kidney Transplant Recipients With Recurrent Complement 3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)03390-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Refining Urgent-Start Peritoneal Dialysis: Definitions, Techniques, and Efficacy for Broader Adoption<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01950-8\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=502c64666e-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-502c64666e-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Early Versus Late Initiation of Dialysis in CKD Stage 5: Time for a Consensus<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01982-X\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=502c64666e-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-502c64666e-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Direct Oral Anticoagulants in Patients With ESRD and Kidney Transplantation<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01939-9\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=502c64666e-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-502c64666e-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Urine Protein-to-Creatinine Ratio Remains Informative Despite Nonsteady State Serum Creatinine During Acute Kidney Injury<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;February&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01989-2\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=5af72f2d40-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-5af72f2d40-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Iptacopan reduces proteinuria and stabilizes kidney function in C3 glomerulopathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00051-8\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=5af72f2d40-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-5af72f2d40-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Thrombotic microangiopathy after kidney transplantation: Insights into genetic etiology and clinical outcomes<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01945-4\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=5af72f2d40-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-5af72f2d40-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Challenges in the diagnosis and management of immune complex-mediated membranoproliferative glomerulonephritis and complement 3 glomerulopathy<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00048-8\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=c2252b1993-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-c2252b1993-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01979-X\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=c2252b1993-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-c2252b1993-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01966-1\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=c2252b1993-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-c2252b1993-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;March&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)03413-2\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=b91e9b13cd-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-b91e9b13cd-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Obinutuzumab and ofatumumab are more effective than rituximab in the treatment of membranous nephropathy patients with anti-rituximab antibodies<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)02055-2\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=b91e9b13cd-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-b91e9b13cd-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Sodium-glucose cotransporter-2 inhibitor in diabetic and nondiabetic renal transplant recipients<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)02034-5\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=b91e9b13cd-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-b91e9b13cd-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Addition of a loop diuretic to norepinephrine during treatment of hepatorenal syndrome type 1<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00099-3\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=07774a6e6a-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-07774a6e6a-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Venous thromboembolism prevention in nephrotic syndrome: The role of aspirin, vitamin K antagonists, and direct oral anticoagulants<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)03387-4\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=07774a6e6a-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-07774a6e6a-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Effects of semaglutide on CKD in patients with type 2 diabetes<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)02003-5\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=07774a6e6a-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-07774a6e6a-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">The role of mitochondria in diabetic kidney disease and potential therapeutic targets<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;April&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00190-1\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=95f6f3381b-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-95f6f3381b-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Dotinurad treatment for patients with hyperuricemia complicating CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00061-0\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=95f6f3381b-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-95f6f3381b-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">An exosomal mRNA urine test for detection and risk stratification of human kidney transplant rejection<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)03406-5\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=95f6f3381b-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-95f6f3381b-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">A targeted-release formulation of budesonide for the treatment of IgA nephropathy patients with severe renal impairment<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00051-8\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=877ec880ff-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-877ec880ff-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Thrombotic microangiopathy after kidney transplantation: Insights into genetic etiology and clinical outcomes<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)03466-1\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=877ec880ff-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-877ec880ff-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Efficacy and safety of rituximab in antiglomerular basement membrane disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00122-6\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=877ec880ff-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-877ec880ff-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Clinical presentation and outcomes of antineutrophil cytoplasmic autoantibody\u2013negative pauci-immune glomerulonephritis<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;May&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)03484-3\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=a8f813280d-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-a8f813280d-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Overview of ADPKD in Pregnancy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00192-5\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=a8f813280d-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-a8f813280d-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">The effect of retatrutide on kidney parameters in participants with type 2 diabetes mellitus and\/or obesity<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00225-6\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=a8f813280d-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-a8f813280d-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\"> Finerenone and estimated GFR slope in type 2 diabetes and CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00232-3\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=dfd1b4090a-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-dfd1b4090a-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Reversible glomerular thrombotic microangiopathy associated with nintedanib in a kidney transplant recipient<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00048-8\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=dfd1b4090a-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-dfd1b4090a-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Open-label, randomized, controlled, crossover trial on the effect of dapagliflozin in patients with ADPKD receiving tolvaptan<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00054-3\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=dfd1b4090a-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-dfd1b4090a-1431833767\" target=\"_blank\" rel=\"noopener noreferrer\">Systematic review of the effects of iron on cardiovascular, kidney, and safety outcomes in patients with CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;June&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00239-6\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=ad60fbadb5-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-ad60fbadb5-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Randomized double-blind placebo-controlled trial of desmopressin for post\u2013kidney biopsy bleeding<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00078-6\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=ad60fbadb5-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-ad60fbadb5-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Persistent B cell depletion after rituximab for autoimmune and glomerular diseases: A case series<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00315-8\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=ad60fbadb5-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-ad60fbadb5-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Long-term outcome of adult patients with membranous nephropathy treated with rituximab<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00190-1\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=474b66736c-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-474b66736c-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Dotinurad treatment for patients with hyperuricemia complicating CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00099-3\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=474b66736c-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-474b66736c-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Venous thromboembolism prevention in nephrotic syndrome: The role of aspirin, vitamin K antagonists, and direct oral anticoagulants<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00193-7\/fulltext?utm_source=ISN+Mailing+list&amp;utm_campaign=474b66736c-Trending+Topics+Journals&amp;utm_medium=email&amp;utm_term=0_-474b66736c-1370262701\" target=\"_blank\" rel=\"noopener noreferrer\">Update on acute tubulointerstitial nephritis: Clinical features, immunologic insights, and diagnostic and treatment approaches<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;July&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00179-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Optimization of Renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00342-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Impact of improved diagnosis and treatment on holistic CKD burden<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00208-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Gut microbiome as a risk factor for future CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00265-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Furosemide and serum protein-bound uremic toxin concentrations in patients with CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00323-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Furosemide, an old friend of nephrologists for the treatment of CKD: Time to rethink the relationship?<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00194-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Holistic impact of CKD: A Clinical, economic, and environmental analysis by IMPACT CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;August&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00239-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Randomized double-blind placebo-controlled trial of desmopressin for post\u2013kidney biopsy bleeding<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00296-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A systematic review of treatment for acute interstitial nephritis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00290-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Impact of CKD on female reproductive hormones<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00225-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Finerenone and estimated GFR slope in type 2 diabetes and CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249%2825%2900255-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Combination cyclophosphamide and rituximab to minimize glucocorticoid use in antineutrophil cytoplasm antibody\u2013associated vasculitis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00263-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Safety of drugs in breastfeeding women with CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00192-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The effect of retatrutide on kidney parameters in participants with type 2 diabetes mellitus and\/or obesity<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00345-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Treatment with avacopan in ANCA\u2013associated vasculitis with kidney involvement<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00245-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Low energy diets for obesity and CKD (SLOW-CKD randomized feasibility study)<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;September&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00419-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Systematic review and network meta-analysis of initial treatments for lupus nephritis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00339-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The double-icodextrin dose randomized controlled trial of a double icodextrin dose for older patients on incremental continuous ambulatory peritoneal dialysis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00464-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Randomized trial of dapagliflozin in patients with nondiabetic stage 4 CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00427-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Cardiovascular complications in ADPKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00284-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Anti-rituximab antibodies occurrence and clinical outcomes in patients with primary membranous nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;October&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00565-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Antiphospholipid syndrome and the kidney<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00386-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Steroid avoidance with low-dose tacrolimus is safe and effective in the long-term for kidney transplant recipients<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00431-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Reassessing rituximab in membranous nephropathy: Efficacy, limitations, and the path ahead<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00412-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A comprehensive framework for kidney function assessment: Summary of the National Institute of Diabetes and Digestive and Kidney Diseases reimagining kidney function assessment workshop<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00420-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Community-acquired acute kidney injury and late kidney dysfunction in survivors of COVID-19 hospitalization<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00413-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Normothermic kidney perfusion: Current status and future perspectives<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;November&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00601-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">From evidence to action: Advancing timely implementation of triple therapy in type 2 diabetes mellitus and CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00472-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Association of British Clinical Diabetologists and UK Kidney Association joint clinical practice guidelines for the pharmacological management of hyperglycemia in adults with type 2 diabetes mellitus and CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00440-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Anti-CD38 daratumumab treatment of chronic active antibody-mediated kidney allograft rejection<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00673-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Povetacicept for IgA nephropathy and primary membranous nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00605-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Evaluating sibeprenlimab in IgA nephropathy &#8211; rationale and baseline data from the VISIONARY trial<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00458-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Novel treatment paradigms: Complement inhibition in antineutrophil cytoplasmic autoantibody vasculitis<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;December&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00601-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">From evidence to action: Advancing timely implementation of triple therapy in type 2 diabetes mellitus and CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00565-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Antiphospholipid syndrome and the kidney<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00664-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Current and emerging therapies for C3 Glomerulopathy and primary (Idiopathic) immune complex membranoproliferative glomerulonephritis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00625-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">CKDs at the crossroads: From failures to future therapies<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00657-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Is it time to consider population-based urine dipstick screening for early detection of kidney disease?<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(25)00607-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Is there a role for rituximab in FSGS therapy in adults?<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][\/vc_tta_section][vc_tta_section title=&#8221;2024&#8243; tab_id=&#8221;2024&#8243; el_class=&#8221;ul-text&#8221;][vc_column_text css=&#8221;.vc_custom_1692881874372{margin-bottom: 20px !important;}&#8221;]<img decoding=\"async\" class=\"alignnone wp-image-32927 size-full\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-46.png\" alt=\"\" width=\"500px\" \/>[\/vc_column_text][vc_toggle title=&#8221;January&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00627-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">KDIGO 2024 Clinical Practice Guideline for the Management of LUPUS NEPHRITIS<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00756-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Glucagon-like Peptide-1 Receptor Signaling Modifies the Extent of Diabetic Kidney Disease Through Dampening the Receptor for Advanced Glycation end Products\u2013induced Inflammation<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00778-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Targeted-release Budesonide Modifies Key Pathogenic Biomarkers in Immunoglobulin A Nephropathy: Insights From the NEFIGAN Trial<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00683-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Conservative Kidney Management and Kidney Supportive Care: Core Components of Integrated Care for People With Kidney Failure<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00696-8\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">IL-22 is Secreted by Proximal Tubule Cells and Regulates DNA Damage Response and Cell Death in Acute Kidney Injury<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00915-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Fibroblastic Reticular Cell-derived Exosomes are a Promising Therapeutic Approach for Septic Acute Kidney Injury<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;February&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00753-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A New Alternative: Inhibiting Complement Activation in Patients With IgA Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00847-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Rationale and Design of the Nephrotic Syndrome Study Network (NEPTUNE) Match in Glomerular Diseases: Designing the Right Trial for the Right Patient, Today<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00611-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Kidney Allograft Venous Obstruction From Polycystic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00627-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">KDIGO 2024 Clinical Practice Guideline for the Management of LUPUS NEPHRITIS<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00756-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Glucagon-like Peptide-1 Receptor Signaling Modifies the Extent of Diabetic Kidney Disease Through Dampening the Receptor for Advanced Glycation end Products-induced Inflammation<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00080-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">An Antigen-specific Chimeric Autoantibody Receptor NK Cell Strategy for the Elimination of Anti-PLA2R1 and Anti-THSD7A Antibody-secreting Cells<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;March&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00744-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA) \u2013 Associated Vasculitis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00863-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Mind the Gap in Kidney Care: Translating What We Know Into What We Do<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00072-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Physiologic Homeostasis After Pig-to-human Kidney Xenotransplantation<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00766-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00169-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Apolipoprotein E is Enriched in Dense Deposits and is a Marker for Dense Deposit Disease in C3 Glomerulopathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00683-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Conservative Kidney Management and Kidney Supportive Care: Core Components of Integrated Care for People With Kidney Failure<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;April&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00171-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The 14th International Podocyte Conference 2023: From Podocyte Biology to Glomerular Medicine<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00073-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Neanderthal Haplotype Introgressed Into the Human Genome Confers Protection Against Membranous Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00086-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Ibrutinib-associated Focal Segmental Glomerulosclerosis and the Impact of Podocin Mutations in Chronic Lymphocytic Leukemia<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00074-7\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Are Biomarkers in Acute Kidney Injury Ready for Prime Time? The Time is Right for a Second Look<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00263-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">NELL-1 Associated Membranous Nephropathy Linked to Skin Fairness Cream use \u2013 Insights From an Indian Case Series<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00082-6\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Charting New Frontiers in IgA Nephropathy: A Paradigm Shift Toward Precision Medicine and Early Intervention?<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;May&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00702-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">An Unusual Complication of Arteriovenous Fistula<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00236-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Phase 2b, Randomized, Double-blind, Placebo-controlled, Clinical Trial of Atacicept for Treatment of IgA Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00069-3\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Biomarker Blues: Balancing Hope and Hype in Acute Kidney Injury<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00169-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Apolipoprotein E is Enriched in Dense Deposits and is a Marker for Dense Deposit Disease in C3 Glomerulopathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00171-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The 14th International Podocyte Conference 2023: From Podocyte Biology to Glomerular Medicine<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00315-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Frailty in Patients on Dialysis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00246-1\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Kidney Protective Mechanisms of SGLT2 Inhibitors: Evidence for a Hemodynamic Effect<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00241-2\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">SGLT2 Inhibitor: 2-way Superstar in Nephrology?<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00243-6\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">SGLT2 Inhibitors Act as Metabolic Transducers to Restore Healthy Nutrient Deprivation and Surplus Signaling in the Kidney<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;June&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00335-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Glycolytic Enzyme PFKFB3 Drives Kidney Fibrosis Through Promoting Histone Lactylation-mediated NF-\u03baB Family Activation<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00334-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Tauroursodeoxycholic Acid Ameliorates Renal Injury Induced by COL4A3 Mutation<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00250-3\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Challenges in the Development of Novel Methodologies for Measuring Glomerular Filtration Rate<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00389-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Role of Complement in Kidney Disease: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00179-0\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Not Too Much, Not Too Little-Just the Right Amount: The Story of YAP in the Podocyte<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00315-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Frailty in Patients on Dialysis<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;July&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00407-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Genetically Inducible Endothelial Niche Enables Vascularization of Human Kidney Organoids With Multilineage Maturation and Emergence of Renin Expressing Cells<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00183-2\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Prognostic Implications of Unbiased Molecular Categorization in Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/kidneyinternational-online.org\/article\/S0085-2538(24)00313-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Long-term Impact of Immediate Versus Deferred Antiretroviral Therapy on Kidney Health in People With HIV<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00379-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">DNA-binding Protein-A Promotes Kidney Ischemia\/Reperfusion Injury and Participates in Mitochondrial Function<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00449-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Clinical Trial Designs to Assess Treatment Effects on Glomerular Filtration Rate Decline<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00083-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">MRI Findings of Renal Cortical Hemosiderosis After Cardiac Valve Surgery<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;August&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00338-7\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Genome-wide Association Study of Hospitalized Patients and Acute Kidney Injury<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00330-2\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Genomics in the Kidney Transplant Clinic: The Future Standard of Care?<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00409-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Visualization of Intracellular ATP Dynamics in Different Nephron Segments Under Pathophysiological Conditions Using the Kidney Slice Culture System<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00534-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The CONVINCE Randomized Trial Found Positive Effects on Quality of Life for Patients With Chronic Kidney Disease Treated With Hemodiafiltration<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00344-2\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Environmental Pollution to Kidney Disease: An Updated Review of Current Knowledge and Future Directions<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00390-9\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Lactate: A Missing Link Between Metabolism and Inflammation in CKD Progression?<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;September&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00406-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Podocyte Density as a Predictor of Long-term Kidney Outcome in Obesity-related Glomerulopathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00457-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Unfairness of Fairness Creams: Unveiling the Toxic Impact on Kidneys of Mercury in Beauty Products<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00337-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Salvaging Donated Kidneys From Prolonged Warm Ischemia During Ex Vivo Hypothermic Oxygenated Perfusion<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00340-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Evaluation of Glomerular Hemodynamic Changes by Sodium-glucose-transporter 2 Inhibition in Type 2 Diabetic Rats Using in Vivo Imaging<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00625-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Randomized, Open-label, Clinical Trial Examined the Effects of Canagliflozin on Albuminuria and eGFR Decline Using an Individual Pre-intervention eGFR Slope<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00464-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Deciphering the Kidney Hemodynamic Effects of SGLT2 Inhibition: Translating Insights From Rats to Humans in Type 2 Diabetes<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;October&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00389-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00480-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Nanotherapeutic kidney cell-specific targeting to ameliorate acute kidney injury<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00546-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Pre-transplant Anti-nephrin Antibodies are Specific Predictors of Recurrent Diffuse Podocytopathy in the Kidney Allograft<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00402-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">An Expert Discussion on the Atypical Hemolytic Uremic Syndrome Nomenclature\u2014Identifying a Road Map to Precision: A Report of a National Kidney Foundation Working Group<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00473-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Controversies and Practical Management of Patients With Gout and Chronic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00455-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Clinical Validation of the Novel Fluorescent Glomerular Filtration Rate Tracer agent Relmapirazin (MB-102)<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;November&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00722-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Effects of Dialysate Potassium Concentration of 3.0mEq\/l wth Sodium Zirconium Cyclosilicate on Dialysis-free Days Versus Dialysate Potassium Concentration of 2.0mEq\/l Alone on Rates of Cardiac Arrhythmias in Hemodialysis Patients With Hyperkalemia<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00700-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">An international, Multi-center Study Evaluated Rituximab Therapy in Childhood Steroid-resistant Nephrotic Syndrome<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00543-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Inhibition of Complement Factor C5a or C5aR for Cholesterol Crystal Embolism\u2013related Vascular Thrombosis With Microvascular Injury and its Consequences<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00534-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The CONVINCE Randomized Trial Found Positive Effects on Quality of Life for Patients With Chronic Kidney Disease Treated With Hemodiafiltration<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00781-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Lupus Nephritis: Redefining the Treatment Goals<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00573-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Transfusion-induced HLA sensitization in Wait-list Patients and Kidney Transplant Recipients<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00694-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Anti-slit Diaphragm Antibodies on Kidney Biopsy Identify Pediatric Patients With Steroid-resistant Nephrotic Syndrome Responsive to Second-line Immunosuppressants<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00553-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Cilastatin, a New Therapeutic Promise for Acute Kidney Injury<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00537-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Iohexol Plasma Clearance Measurement Protocol Standardization for Adults: a Consensus Paper of the European Kidney Function Consortium<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;December&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00628-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Myeloperoxidase-ANCA IgG Induces Different Forms of Small Vessel Vasculitis Based on Type of Synergistic Immune Stimuli<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00565-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Evaluation of Non-invasive Biomarkers of Kidney Allograft Rejection in a Prospective Multicenter Unselected Cohort Study (EU-TRAIN)<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(24)00629-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Randomized Phase 2b Trial Examined the Effects of the Glucagon-like Peptide-1 and Glucagon Receptor Agonist Cotadutide on Kidney Outcomes in Patients With Diabetic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_column_text css=&#8221;.vc_custom_1692881881245{margin-bottom: 20px !important;}&#8221;]<img decoding=\"async\" class=\"alignnone wp-image-32927 size-full\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45.png\" alt=\"\" width=\"500px\" srcset=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45.png 1202w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-1024x72.png 1024w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-768x54.png 768w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-640x45.png 640w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-400x28.png 400w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-367x26.png 367w\" sizes=\"(max-width: 1202px) 100vw, 1202px\" \/>[\/vc_column_text][vc_toggle title=&#8221;January&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01615-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Novel Treatment Paradigms: Primary IgA Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01599-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Kidney Diseases Associated With Inflammatory Bowel Disease: Impact of Chronic Histologic Damage, Treatments, and Outcomes<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01629-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">C3 Glomerulopathy: Novel Treatment Paradigms<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01632-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Framework of Guidelines for Management of CKD in Asia<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00035-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Pathologic Spectrum of Kidney Diseases Within Very Elderly Patients Who Underwent Kidney Biopsy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01637-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis From Minimal Change Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;February&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00014-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">\u201cEculizumab First\u201d in the Management of Posttransplant Thrombotic Microangiopathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00021-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Prospective Study on Individualized Dose Adjustment of Tolvaptan Based on Urinary Osmolality in Patients With ADPKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01642-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Role of Sodium-Glucose Cotransporter-2 Inhibitors in the Treatment Paradigm of CKD in Africa: An African Association of Nephrology Panel Position Paper<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01615-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Novel Treatment Paradigms: Primary IgA Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00002-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Alkaline Phosphatase and Parathyroid Hormone Levels: International Variation and Associations With Clinical Outcomes in the DOPPS<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00015-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Randomized Controlled Study of Efficacy and Safety of Accelerated Versus Standard Hepatitis B Vaccination in Patients With Advanced CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;March&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01495-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Clinical Characteristics and Outcomes of NELL1-Associated Membranous Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00048-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Complement and Podocytopathies: Do We Have a New Biomarker?<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00103-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Pilot Study on the Safety and Adequacy of a Novel Ecofriendly Hemodialysis Prescription-Green Nephrology<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00021-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Prospective Study on Individualized Dose Adjustment of Tolvaptan Based on Urinary Osmolality in Patients With ADPKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00049-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Barriers to Optimal Kidney Health Among Indigenous Peoples<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01494-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Fournier\u2019s Gangrene in a Patient With CKD Without Diabetes Possibly Related to Sodium-Glucose Cotransporter 2 Inhibitor Therapy<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;April&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01482-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Aversion to a High Salt Taste is Disturbed in Patients With CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01580-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Performance Evaluation of an Automated Peritoneal Dialysis Solution Generation System in Patients Using Automated Peritoneal Dialysis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00093-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Transplant-inclusive Value-based Kidney Care Payment Model<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01605-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Real-world Experience With Avacopan in Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00061-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">What is the Appropriate Dose of Tolvaptan in ADPKD?<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00037-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Genetic Diagnosis of Adult Hemodialysis Patients With Unknown Etiology<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;May&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01504-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">WCN\u201924-1506 Efficacy and Safety of Iptacopan in Patients With IgA Nephropathy: Interim Results From the Phase 3 APPLAUSE-IgAN Study<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01585-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)00130-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">WCN\u201924-967 Acute Kidney Injury Due to Adenia Ellenbeckii Poisoning. A Case Report<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01678-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Infectious Disease Prophylaxis During and After Immunosuppressive Therapy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01521-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Predictive Factors of Renal Recovery and Progression to End-stage Kidney Disease in Patients With Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis With Severe Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01529-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Nedosiran Safety and Efficacy in PH1: Interim Analysis of PHYOX3<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01711-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Obinutuzumab as Initial or Second-line Therapy in Patients With Primary Membranous Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01719-4\/fulltext\" target=\"_blank\" rel=\"noopener\">Clinicopathologic Features of IgG4-related Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01736-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Elevated Exposure to Air Pollutants Accelerates Primary Glomerular Disease Progression<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;June&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01651-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Effects of Once-weekly Semaglutide on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01692-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Torque Teno Virus-guided Immunosuppression in Kidney Transplantation: Expanding the Application<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01699-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Description and Cross-sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01739-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01752-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Key Points in Managing PLA2R-associated Membranous Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01769-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Acute Kidney Injury and Hair-straightening Products<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;July&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01755-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Corticosteroids in Patients With IgA Nephropathy: Is the Lower the Better?<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01798-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Certain Red Yeast Rice Supplements in Japan Cause Acute Tubulointerstitial Injury<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01699-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Description and Cross-sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01815-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Antinephrin-associated Primary Focal Segmental Glomerulosclerosis Successfully Treated With Plasmapheresis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01794-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Phase 1b\/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-phospholipase A2 Receptor Autoantibody-positive Primary Membranous Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01796-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Global aHUS Registry Analysis of Patients Switching to Ravulizumab From Eculizumab<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;August&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01828-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Biomarkers of Kidney Disease Progression in ADPKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01754-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Dialysis Discontinuation, Prognosis, and Shared Decision-making<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01823-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Avacopan in Anti-neutrophil Cytoplasmic Autoantibodies-associated Vasculitis in a Real-world Setting<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01711-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Obinutuzumab as Initial or Second-Line Therapy in Patients With Primary Membranous Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01824-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Lower Parathyroid Hormone Levels are Associated With Reduced Fracture Risk in Japanese Patients on Hemodialysis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01809-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Randomized Controlled Trial Comparing Automated Peritoneal Dialysis and Hemodialysis for Urgent-start Dialysis in ESRD<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;September&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01794-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Phase 1b\/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-phospholipase A2 Receptor Autoantibody-positive Primary Membranous Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01823-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Avacopan in Anti-neutrophil Cytoplasmic Autoantibodies\u2013associated Vasculitis in a Real-world Setting<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01850-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">N-acetylcysteine in Kidney Disease: Molecular Mechanisms, Pharmacokinetics, and Clinical Effectiveness<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01706-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Implementation and Evaluation of a National Multidisciplinary Kidney Genetics Clinic Network Over 10 Years<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01745-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Cardioprotective Effect of SGLT2 Inhibitor in Diabetic Kidney Transplant Recipients: A Multicenter Propensity Score Matched Study<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01710-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Clinical Characteristics of Nephrin Autoantibody-positive Minimal Change Disease in Older Adults<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;October&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01739-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01797-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Importance of IFT140 in Patients with Polycystic Kidney Disease Without a Family History<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01921-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Combination Therapy With Rituximab and Low-dose Cyclophosphamide and Prednisone in Membranous Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01815-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Antinephrin-Associated Primary Focal Segmental Glomerulosclerosis Successfully Treated With Plasmapheresis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01719-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Clinicopathologic Features of IgG4-Related Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01852-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Keep Calm and Dialyze On: Debunking the Myths of Peritoneal Dialysis Leaks<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;November&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01897-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Role of Urate in Calcium Stone Formation<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01684-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Spectrum of Kidney Biopsy Findings Associated With Methamphetamine Use<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01912-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Impact of Different Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker Resumption Timing on Post Acute Kidney Injury Outcomes<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01854-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\"> Imlifidase in Highly Sensitized Kidney Transplant Recipients With a Positive Crossmatch Against a Deceased Donor<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01829-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01752-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Key Points in Managing PLA2R-associated Membranous Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01796-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Global aHUS Registry Analysis of Patients Switching to Ravulizumab From Eculizumab<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01945-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 Glomerulopathy<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;December&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01862-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Review of Exercise Interventions to Improve Clinical Outcomes in Nondialysis CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01942-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">SGLT2-Inhibition in Patients With Alport Syndrome<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(24)01883-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Urinary Soluble CD163: A Novel Biomarker Suggests Who Should Receive Glucocorticoids in IgA Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][\/vc_tta_section][vc_tta_section title=&#8221;2023&#8243; tab_id=&#8221;2023&#8243; el_class=&#8221;ul-text&#8221;][vc_column_text css=&#8221;.vc_custom_1692881874372{margin-bottom: 20px !important;}&#8221;]<img decoding=\"async\" class=\"alignnone wp-image-32927 size-full\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-46.png\" alt=\"\" width=\"500px\" \/>[\/vc_column_text][vc_toggle title=&#8221;April&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00054-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Interference of UACR Measurement by Glycosuria: Clinical Implications When Using SGLT-2 Inhibitors<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00056-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Post hoc Analysis suggests People With Type 2 Diabetes treated with Semaglutide experience more stable Kidney Function<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00122-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Novel Direct AMPK Activator Ameliorates Disease Progression in Preclinical Models of ADPKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00076-5\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Glucocorticoids for IgA Nephropathy-pro<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00075-3\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">First do no Harm: Systemic Glucocorticoids Should not be Used for the Treatment of Progressive IgA Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00174-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">International Society of Nephrology First Consensus Guidance for Preclinical Animal Studies in Translational Nephrology<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;May&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00267-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Single Cell Landscape of Parietal Epithelial Cells in Healthy and Diseased States<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00182-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Prospective, Randomized, Multicenter Clinical Study Comparing a Self-expanding Covered Stent to PTA for Treatment of AVF Stenosis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00176-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Perspectives on Early Detection of Chronic Kidney Disease: the Facts, the Questions, and a Proposed Framework for 2023 and Beyond<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00170-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Podocyte Protease Activated Receptor 1 Stimulation in Mice Produces FSGS Mirroring Human Disease Signaling Events<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00074-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">IgA Nephropathy and Glucocorticoids \u2013 a Limbo Dance?<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00146-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Novel MUC1 Variant Identified by Massively Parallel Sequencing Explains Interstitial Kidney Disease in a Large Dutch Family<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;June&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00379-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Novel Anemia Therapies in Chronic Kidney Disease: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00394-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Bio-impedance Spectroscopy Added to a Fluid Management Protocol Does not Improve Preservation of Residual Kidney Function in Incident Hemodialysis Patients in a Randomized Controlled Trial<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00249-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Quality of Life: A Crucial Aspect for the Patients, a Neglected Goal in the Treatment of Anemia in Patients with CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00395-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">IgA Nephropathy: The Lectin Pathway and Implications for Targeted Therapy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00331-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Application of the Banff Human Organ Transplant Panel to Kidney Transplant Biopsies With Features Suspicious for Antibody-mediated Rejection<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00309-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Effects of Newer Kidney Protective Agents on Kidney Endpoints Provide Implications for Future Clinical Trials<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00314-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Water Implications in Dialysis Therapy, Threats and Opportunities to Reduce Water Consumption: A Call for the Planet<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00328-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Peroxiredoxin 1 Aggravates Acute Kidney Injury by Promoting Inflammation Through Mincle\/Syk\/NF-\u03baB Signaling<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00266-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Hypoxia Hits APOL1 in the Kidney<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;July&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00493-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Novel Mechanisms of Salt-sensitive Hypertension<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00400-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Axolotl Kidney: A Novel Model to Study Kidney Regeneration<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00481-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">PCSK9 Targets Megalin in the Kidney Proximal Tubule and Aggravates Proteinuria in Nephrotic Syndrome<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00418-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Effectiveness of Diuretics and CCBs on Top of RAS Inhibitors on CKD Progression and Mortality<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00315-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Green Nephrology: Minimizing the Environmental Impact of Kidney Health Care<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;August&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00540-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Vitamin D Supplementation in People With Chronic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00537-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Sodium Glucose Co-transporter 2 Inhibition Increases Epidermal Growth Factor Expression and Improves Outcomes in Patients With Type 2 Diabetes<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00502-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Deletion of Protein Tyrosine Phosphatase SHP-1 Restores SUMOylation of Podocin and Reverses the Progression of Diabetic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00399-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Managing the Symptom Burden Associated With Maintenance Dialysis: Conclusions From a KDIGO Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00396-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Kidney-centric View of Pre-eclampsia Through the Kidney-placental Bidirectional Lens<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00473-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Rare Variants in the Sodium-dependent Phosphate Transporter Gene SLC34A3 Explain Missing Heritability of Urinary Stone Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;September&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00564-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Comprehensive Description of Kidney Disease Progression After Acute Kidney Injury From a Prospective, Parallel-group Cohort Study<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00384-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">One Antigen Closer to Understanding Membranous Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00610-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Post Hoc Analysis of the SONAR Trial Indicates That the Endothelin Receptor Antagonist Atrasentan is Associated With Less Pain in Patients With Type 2 Diabetes and Chronic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00601-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The ASSESS-AKI Study Found Urinary Epidermal Growth Factor is Associated With Reduced Risk of Major Adverse Kidney Events<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00491-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Fluid Management Protocols in Hemodialysis Patients Using Bioimpedance Validation: Time to Look Elsewhere?<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;October&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00490-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00540-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Vitamin D Supplementation in People With Chronic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00537-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\"> Sodium Glucose Co-transporter 2 Inhibition Increases Epidermal Growth Factor Expression and Improves Outcomes in Patients With Type 2 Diabetes<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00399-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Managing the Symptom Burden Associated With Maintenance Dialysis: Conclusions From a Kidney Disease \u2013 Improving Global Outcomes (KDIGO) Controversies Conference<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00396-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Kidney-centric View of Pre-eclampsia Through the Kidney-placental Bidirectional Lens<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00473-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Rare Variants in the Sodium-dependent Phosphate Transporter Gene SLC34A3 Explain Missing Heritability of Urinary Stone Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;November&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00674-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">A Novel Multi-ancestry Proteome-wide Mendelian Randomization Study Implicates Extracellular Proteins, Tubular Cells, and Fibroblasts in Estimated Glomerular Filtration Rate Regulation<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00678-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Glomerular-tubular Crosstalk via Cold Shock Y-box Binding Protein-1 in the Kidney<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00676-2\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Evaluation of the Stopping Angiotensin Converting Enzyme Inhibitor Compared to Angiotensin Receptor Blocker (STOP ACEi Trial) in Advanced and Progressive Chronic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00754-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Results of a Randomized Double-blind Placebo-controlled Phase 2 Study Propose Iptacopan as an Alternative Complement Pathway Inhibitor for IgA Nephropathy.<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00679-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">An Introduction to Realist Evaluation and Synthesis for Kidney Research<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00681-6\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\"> Mendelian Randomization for Nephrologists<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;December&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00762-7\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Anti-obesity Pharmacotherapy in Adults With Chronic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00565-3\/abstract\" target=\"_blank\" rel=\"noopener noreferrer\">Abnormal Lactate Metabolism is Linked to Albuminuria and Kidney Injury in Diabetic Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00761-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Unveiling a New Era With Liquid Chromatography Coupled With Mass Spectrometry to Enhance Parathyroid Hormone Measurement in Patients With Chronic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00490-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00778-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Targeted-release Budesonide Modifies Key Pathogenic Biomarkers in Immunoglobulin A Nephropathy: Insights From the NEFIGAN Trial<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00492-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Valacyclovir-associated Acute Kidney Injury<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_column_text css=&#8221;.vc_custom_1692881881245{margin-bottom: 20px !important;}&#8221;]<img decoding=\"async\" class=\"alignnone wp-image-32927 size-full\" src=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45.png\" alt=\"\" width=\"500px\" srcset=\"https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45.png 1202w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-1024x72.png 1024w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-768x54.png 768w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-640x45.png 640w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-400x28.png 400w, https:\/\/www.theisn.org\/wp-content\/uploads\/2023\/08\/MicrosoftTeams-image-45-367x26.png 367w\" sizes=\"(max-width: 1202px) 100vw, 1202px\" \/>[\/vc_column_text][vc_toggle title=&#8221;April&#8221;]Shutterstock<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01191-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Unmet Needs of CKD in Latin America: A Review from Expert Virtual Working Group<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)00043-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01166-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Factor B Mutation in Monozygotic Twins Discordant for Atypical Hemolytic Uremic Syndrome<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)00049-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Narrative Review of Glycemic Management in People With Diabetes on Peritoneal Dialysis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01228-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Atypical Anti-Glomerular Basement Membrane Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)00045-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Pregnancy History and Kidney Disease Progression Among Women Enrolled in Cure Glomerulonephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;May&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01294-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Interplay Between Dietary Sodium Intake and Proteinuria in CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01288-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">An International Survey of Peritoneal Dialysis Exercise Practices and Perceptions<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01271-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Managing Hyperkalemia in the Modern Era: A Case-based Approach<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01248-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Heterogeneity of Target Antigens in Sarcoidosis-Associated Membranous Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01233-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Multiomics Analysis of Plasma Proteomics and Metabolomics of Steroid Resistance in Childhood Nephrotic Syndrome Using a \u201cPatient-Specific\u201d Approach<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01229-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Randomized Trial on the Effect of Oral Potassium Chloride Supplementation on the NCC in Healthy Adults<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;June&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01317-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Long-Term Efficacy and Safety of Rituximab Versus Tacrolimus in Children With Steroid Dependent Nephrotic Syndrome<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01309-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Assessing the Accuracy of ChatGPT on Core Questions in Glomerular Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01301-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Clinicopathologic Spectrum of Lysozyme-associated Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01271-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Managing Hyperkalemia in the Modern Era: A Case-based Approach<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01312-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Avacopan in Patients With Rapidly Progressive Glomerulonephritis Requiring Dialysis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01215-9\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Evidence for Kidney Volume as a Measure of ADPKD Severity \u201cMarches On\u201d in the OVERTURE Study<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01283-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Introducing the International Home Dialysis Consortium<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01295-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Prescribing Patterns for Sodium-glucose Cotransporter 2 Inhibitors: A Survey of Nephrologists<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;July&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01367-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Effect of Belimumab on Preventing de Novo Renal Lupus Flares<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01334-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Worldwide Exploration of Renal Replacement Outcomes Collaborative in Kidney Disease (WE-ROCK)<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01356-6\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Randomized Controlled Clinical Trial of Treatment With Vitamin K2 on Vascular Calcification in Hemodialysis Patients (Trevasc-HDK)<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;August&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01394-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Children With Steroid Dependent Nephrotic Syndrome: Rituximab or Tacrolimus? It\u2019s All in the Timing<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01395-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Cardiovascular Manifestations and Management in ADPKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01402-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Targeting the Endothelin A Receptor in IgA Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01368-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Association Between Metabolic Syndrome, Hyperfiltration, and Long-term GFR Decline in the General Population<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01381-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Diagnosis of Kidney Diseases of Unknown Etiology Through Biopsy-genetic Analysis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01389-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Donor-derived Cell-free DNA in Biopsy-proven Antibody-mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;September&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01420-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Randomized Study of Tenapanor Added to Phosphate Binders for Patients With Refractory Hyperphosphatemia<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01426-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Twitter as Educational Tool: A Global Web-based Cross-sectional Study on Social Media Behavior of Nephrologists<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01388-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">The Phenotypic Spectrum of COL4A3 Heterozygotes<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01399-2\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Residual Kidney Function and Cause-specific Mortality Among Incident Hemodialysis Patients<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01417-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Clinical Characteristics and Outcomes of Drug-induced Acute Kidney Injury Cases<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01411-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Regional Variation in Hemoglobin Distribution Among Individuals With CKD: the ISN International Network of CKD Cohorts<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;October&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01536-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Updates on New Therapies for Patients with Chronic Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01402-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Targeting the Endothelin A Receptor in IgA Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01395-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Cardiovascular Manifestations and Management in ADPKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01420-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Randomized Study of Tenapanor Added to Phosphate Binders for Patients With Refractory Hyperphosphatemia<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01516-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Non-Fluoroscopic Techniques to Insert a Tunneled Hemodialysis Catheter<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01479-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Classifying Hypotonic Hyponatremia by Projected Treatment Effects \u2013 A Quantitative 3-Dimensional Framework<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;November&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01484-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\"> Patient Survival With Extended Home Hemodialysis Compared to In-center Conventional Hemodialysis<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01510-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01528-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Tenapanor as Add-on Treatment for Hyperphosphatemia in Dialysis Patients: Enough Bang for the Buck?<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01566-8\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Exercise-Induced Fluid Retention, Cardiac Volume Overload, and Peripheral Edema in Ultra-Distance Cyclists<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01539-5\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\"> Systematic Review of Cardiovascular Benefits and Safety of Sacubitril-Valsartan in End-Stage Kidney Disease<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01555-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Mycophenolate Mofetil and Steroid for Treatment of Patients With IgA Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][vc_toggle title=&#8221;December&#8221;]<\/p>\n<ul class=\"porto-info-list ki-list\">\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01562-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Iptacopan in Idiopathic Immune Complex\u2013Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01541-3\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Beyond Serology: Is There Still a Value of Kidney Biopsy in Anti-Glomerular Basement Membrane Disease?<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01599-1\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Kidney Diseases Associated with Inflammatory Bowel Disease: Impact of Chronic Histologic Damage, Treatments and Outcomes<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01536-X\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Updates on New Therapies for Patients With CKD<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01615-7\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Novel Treatment Paradigms: Primary IgA Nephropathy<\/a><\/h5>\n<\/div>\n<\/li>\n<li class=\"porto-info-list-item\">\n<div class=\"porto-info-list-item-desc\">\n<h5 class=\"post-item-title\"><a href=\"https:\/\/www.kireports.org\/article\/S2468-0249(23)01576-0\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">Impact of Remote Monitoring on Standardized Outcomes in Nephrology-Peritoneal Dialysis<\/a><\/h5>\n<\/div>\n<\/li>\n<\/ul>\n<p>[\/vc_toggle][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row el_class=&#8221;trending&#8221;][vc_column][vc_single_image image=&#8221;54148&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221; css=&#8221;.vc_custom_1780299543613{margin-bottom: 0px !important;padding-bottom: 10px !important;}&#8221;][vc_column_text css=&#8221;.vc_custom_1788950982413{margin-bottom: 20px !important;border-top-width: 2px !important;padding-top: 25px !important;border-top-color: #00337c !important;border-top-style: solid !important;}&#8221;]Explore highly downloaded* research and real-world clinical insights from Kidney International\u00ae, Kidney International Reports\u00ae, and Kidney International Case Reports\u2122. Turn your clinical experience into global knowledge with Kidney International Case Reports\u2122. Find out how to [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":144,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-32851","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/pages\/32851"}],"collection":[{"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/comments?post=32851"}],"version-history":[{"count":7,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/pages\/32851\/revisions"}],"predecessor-version":[{"id":55289,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/pages\/32851\/revisions\/55289"}],"up":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/pages\/144"}],"wp:attachment":[{"href":"https:\/\/www.theisn.org\/wp-json\/wp\/v2\/media?parent=32851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}